Nan Fung Group Holdings »

Maplight Therapeutics shares owned by Nan Fung Group Holdings

Quarter-by-quarter ownership of Maplight Therapeutics (MPLT) shares owned by Nan Fung Group Holdings from 13F filings

Historical chart of Nan Fung Group Holdings investment in Maplight Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Maplight Therapeutics held by Nan Fung Group Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maplight Therapeutics by Nan Fung Group Holdings

Quarter filed Position value Share count Share price at filing
2026-06-30 $35M 971k 35.84
2026-03-31 $20M 971k 20.33
2025-12-31 $17M 971k 17.57

More positions owned by Nan Fung Group Holdings

Maplight Therapeutics (MPLT)
Lb Pharmaceuticals Com Shs (LBRX)
Evommune Com Shs (EVMN)
Cybin Com New (HELP)
Incyte Corporation (INCY)
Rhythm Pharmaceuticals (RYTM)
Beone Medicines Sponsored Ads (ONC)
Oculis Holding Ordinary Shares (OCS)
Ascendis Pharma A/s Ord Shs (ASND)
Revolution Medicines (RVMD)
Kymera Therapeutics (KYMR)
Madrigal Pharmaceuticals (MDGL)
Celcuity (CELC)
ACADIA Pharmaceuticals (ACAD)
Argenx Se Sponsored Adr (ARGX)

View all positions for Nan Fung Group Holdings

Top funds holding Maplight Therapeutics

Novo A/S
Fcpm Iii Services B.v.
Goldman Sachs Group
BlackRock
Nan Fung Group Holdings
5AM Venture Management
Sanofi
FMR
Vanguard Capital Management
Blue Owl Capital Holdings
Paradigm Biocapital Advisors
Pivotal bioVenture Partners Investment Advisor
Velan Capital Investment Management
Siren
Geode Capital Management

View all funds holding Maplight Therapeutics